Medical OfficerPatan Academy of Health SciencesLalitpur, Bagmati, Nepal
OC 42.5 - Hemorrhagic risk of Caplacizumab in the treatment of Thrombotic thrombocytopenic purpura A pharmacovigilance study from 2020-2022 FAERS Database.
Monday, June 26, 202315:45 – 16:00 ET
PB0933 - Somatic CALR1 vs. CALR2 mutation in Patients with Essential Thrombocythemia and the Risk of Thrombosis. A systemic review and meta-analysis.
Monday, June 26, 202318:30 – 19:30 ET
